(Q34343280)

1 August 2017

1 reference

title

Bacteria-derived particles as adjuvants for non-replicating nasal vaccines (English)

1 reference

1 August 2017

Haneberg B

1

1 reference

1 August 2017

Herland Berstad AK

series ordinal

2

1 reference

1 August 2017

Holst J

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

143-147

1 reference

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Epithelial M cells: gateways for mucosal infection and immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900163-6

7 January 2021

10.1016/S0169-409X(01)00163-6

Identifiers

DOI

1 reference

release_vw6sb3ke2rb53ju7bbzi7lhuxm

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vw6sb3ke2rb53ju7bbzi7lhuxm

24 November 2022

mapped directly with Wikidata item

1 reference